cholestyramine resin has been researched along with Bright Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Audetat, V; Bircher, J | 1 |
| Mimura, K; Yukawa, S | 1 |
2 other study(ies) available for cholestyramine resin and Bright Disease
| Article | Year |
|---|---|
Bioavailability of prednisolone during simultaneous treatment with cholestyramine.
Topics: Biological Availability; Cholestyramine Resin; Glomerulonephritis; Humans; Prednisolone | 1976 |
[Hyperlipidemia and drug treatment].
Topics: Arteriosclerosis; Carnitine; Cholestyramine Resin; Glomerulonephritis; Humans; Hyperlipidemias; Kidney Failure, Chronic; Niceritrol; Pantetheine; Pravastatin; Probucol; Vitamin E | 1991 |